Van Lanschot Kempen
Overview
Van Lanschot Kempen is a specialized, independent wealth manager that provides private banking, investment management, and investment banking services to wealthy individuals and institutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AgomAb Therapeutics | Feb 2026 | IPO | Lead |
| HealthifyMe | Oct 2024 | Series D | Co-investor |
| AgomAb Therapeutics | Feb 2024 | IPO | Co-investor |
| HealthifyMe | Jun 2023 | Growth Equity | Co-investor |
| Arrimaq | Oct 2018 | IPO | Co-investor |
Key People
Felix Rutten
Portfolio Manager - Vice President - Manager Research Solutions
Amy Vogel
Principal Associate, Wholesale and Institutional Clients
Alice MacNeil
Portfolio Manager - SDG Farmland Fund
Andreas Welter
Director, Senior Portfolio Manager Global REITs at Van Lanschot Kempen
Angela Labarile
Portfolio Manager
Arif Bagasrawalla
Senior Portfolio Manager Fixed Income
Daniel Riddaway
Senior Portfolio Manager
Drew Milgate
Portfolio Manager
Egbert Nijmeijer
Co-Head Real Assets, Senior Portfolio Manager Real Estate
Erin Yeung
Portfolio Manager
Erwin Dut
Senior Portfolio Manager
Guilherme Teixeira
Senior Portfolio Manager
Harold van Acht
Senior Portfolio Manager Fixed Income
Ingmar Schaefer
Senior Portfolio Manager
Isaura Wolswijk MRE
Portfolio Manager Non-Listed Real Estate Real Assets
Jags Walia
Senior Portfolio Manager, and ESG Council member
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
